Bioness Medical Acquires the PoNS (Portable Neuromodulation Stimulator) System Product Line
April 9, 2026
Bioness Medical, Inc. announced the acquisition of the PoNS (Portable Neuromodulation Stimulator) System product line. The deal expands Bioness’s neurorehabilitation platform from functional electrical stimulation (FES) into non-invasive central neuromodulation delivered via the tongue, supporting multi-modal treatment for patients with gait and balance disorders.
- Buyers
- Bioness Medical, Inc.
- Targets
- PoNS (Portable Neuromodulation Stimulator) System product line
- Industry
- Medical Devices
- Location
- California, United States
- Transaction Type
- Addon
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.